HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

(ACTRIMS 2017) Cutting-edge developments in MS research

404 Views 0 Replies

0 Members and 1 Guest are viewing this topic.

(ACTRIMS 2017) Cutting-edge developments in MS research
on:
#1
Multiple Sclerosis Journal has sent a list of "breaking news" abstracts from the ACTRIMS conference held in February in Orlando, FL:

http://journals.sagepub.com/doi/full/10.1177/1352458517693714
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.